Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |